Literature DB >> 4449517

The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection.

R Jennings, C M Brand, C McLaren, L Shepherd, C Potter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4449517     DOI： 10.1007/BF02121445

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  14 in total

1.  Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.

Authors:  R Jennings; C W Potter; C McLaren
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

2.  Studies on the origin of pandemic influenza. I. Antigenic analysis of A 2 influenza viruses isolated before and after the appearance of Hong Kong influenza using antisera to the isolated hemagglutinin subunits.

Authors:  R G Webster; W G Laver
Journal:  Virology       Date:  1972-05       Impact factor: 3.616

3.  The Hong Kong-68 influenza A2 variant.

Authors:  M T Coleman; W R Dowdle; H G Pereira; G C Schild; W K Chang
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

4.  Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection.

Authors:  C W Potter; R Jennings; R C Rees; C McLaren
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

5.  Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.

Authors:  C W Potter; R Jennings; W M Marine; C McLaren
Journal:  Microbios       Date:  1973 Sep-Oct

6.  Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants.

Authors:  W R Dowdle; W M Marine; M Coleman; V Knez
Journal:  J Gen Virol       Date:  1972-08       Impact factor: 3.891

7.  A quantitative, single-radial-diffusion test for immunological studies with influenza virus.

Authors:  G C Schild; M Henry-Aymard; H G Pereira
Journal:  J Gen Virol       Date:  1972-08       Impact factor: 3.891

8.  Immunological interrelationships of Hong Kong, Asian and equi-2 influenza viruses in man.

Authors:  W M Marine; W M Workman; R G Webster
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

9.  Influenza virus infection in the hamster; a study of inapparent virus infection and virus adaptation.

Authors:  W F FRIEDEWALD; E W HOOK
Journal:  J Exp Med       Date:  1948-09-01       Impact factor: 14.307

10.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307
View more
  6 in total

1.  A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity.

Authors:  M I Brady; I G Furminger
Journal:  J Hyg (Lond)       Date:  1976-10

2.  A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.

Authors:  R Jennings; C W Potter; C McLaren; M Brady
Journal:  J Hyg (Lond)       Date:  1975-12

3.  Influenza virus infection of hamsters. A model for evaluating antiviral drugs.

Authors:  H E Renis
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

4.  Killer T cell responses to influenza A during a drift period: studies in mice.

Authors:  D Armerding; H Rossiter; E Liehl
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

5.  The hamster as an experimental animal for the study of influenza. I. The role of antibody in protection.

Authors:  R Jennings; M D Denton; C W Potter
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

6.  Artificial cells: from basic science to applications.

Authors:  Can Xu; Shuo Hu; Xiaoyuan Chen
Journal:  Mater Today (Kidlington)       Date:  2016-11       Impact factor: 31.041
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.